Precigen, Inc.
MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
Last updated:
Abstract:
Provided herein are chimeric antigen receptors (CARs) for cancer therapy, and more particularly, CARs containing a scFv from an anti-MUC16 monoclonal antibody. Provided are immune effector cells containing such CARs, and methods of treating proliferative disorders.
Status:
Application
Type:
Utility
Filling date:
4 Feb 2022
Issue date:
19 May 2022